SlideShare ist ein Scribd-Unternehmen logo
1 von 16
Downloaden Sie, um offline zu lesen
3Q06 Earnings Results

   November 14, 2006
Forward Looking Statement

This presentation contains certain statements that are neither reported financial results or
other historical information. They are forward-looking statements.


Because these forward-looking statements are subject to risks and uncertainties, actual
future results may differ materially from those expressed in or implied by the statements.
Many of these risks and uncertainties relate to factors that are beyond CCR’s ability to
control or estimate precisely, such as future market conditions, currency fluctuations, the
behavior of other market participants, the actions of governmental regulators, the
Company's ability to continue to obtain sufficient financing to meet its liquidity needs; and
changes in the political, social and regulatory framework in which the Company operates or
in economic or technological trends or conditions, inflation and consumer confidence, on a
global, regional or national basis.


Readers are cautioned not to place undue reliance on these forward-looking statements,
which speak only as of the date of this document. CCR does not undertake any obligation
to publicly release any revisions to these forward looking statements to reflect events or
circumstances after the date of this presentation.

                                               2
Agenda



   Highlights



   Results



   Outlook




                3
Highlights

 Operating
    Consolidated traffic recovery, when compared to recent quarters, up by
    2.4% over the third quarter, 2005.
    25.4% Increase in AVI users, totaling 632th.




 Corporate

    On August 31, 2006, the Company initiated a dividend payment, which was
    recorded as anticipated dividends regarding FY 2006 results, amounting to
    R$ 254.0 million, representing a dividend payout ratio of 131% over 1H06’s
    Net Income.


                                         4
Results

  3Q06’s results reflect a combination of factors...


  R$ Million                                                      3Q05               3Q06               chg %      9M05      9M06      chg %
  Net Revenues                                                    519.3              550.0               5.9%     1,402.4   1,577.4    12.5%
  Total Cost (1)                                                  290.5              315.5               8.6%      830.3     954.9     15.0%
  EBIT                                                            228.9              234.6               2.5%      572.1     622.5      8.8%
  EBIT Margin                                                     44.1%              42.7%             -1.4 p.p    40.8%     39.5%    -1.3 p.p
  Depreciation & Amortization (2)                                  81.3               87.9               8.1%      221.1     261.0     18.1%
  EBITDA                                                          310.2              322.4               3.9%      793.2     883.6     11.4%
  EBITDA margin                                                   59.7%              58.6%             -1.1 p.p    56.6%     56.0%    -0.6 p.p
  Net Financial Result                                             47.9              (48.7)           -201.7%      (25.0)   (143.0)   472.8%
  Net Income                                                      182.3              121.1             -33.6%      347.9     314.5     -9.6%
                 Net Financial Result (3)                         (47.1)             (48.7)             3.7%      (120.0)   (143.0)    19.3%
                         Net Income (3)                           120.2              121.1              0.9%       285.8    314.5      10.1%
 (1) Total Cost + Administrative Expenses
 (2) Includes Prepaid Expenses
 (3) Pro forma amounts, excluding fiscal contingencies reversin in 3Q05 – net amount of R$ 62.1 million




                                                                                          …operating costs and financial result.
                                                                                         5
Operating Margin Evolution

                                                                EBITDA x EBITDA Margin
  R$ (million)




                                                                                                                  310    309                     322
                                                                                                                                 299
                                                                                                           259                           263
                                                                                      216    218    224

                                                         161     170    174
                                                                               151
                        130     128        122    119
  108            107
                                                                                                                  60%            58%             59%
                                                         53%                          55%    55%    54%    55%           56%
                        49%                                      51%    52%                                                              51%
 46%             46%            47%       48%     47%                          44%


 1Q02            2Q02   3Q02    4Q02      1Q03    2Q03   3Q03    4Q03   1Q04   2Q04   3Q04   4Q04   1Q05   2Q05   3Q05   4Q05    1Q06    2Q06    3Q06




                                                   Adjusted EBITDA x Adjusted EBITDA margin
 R$ (million)




                                                                                                                   375    374                     386
                                                                                                                                  362
                                                                                                            319                           326
                                                                                      266     269    276
                                                                 211    218
                                                         203                   196
                        163      162       155    152
  138            137
                                                                                                                  72%            70%             70%
                                                         67%            66%           68%    68%    67%    68%           68%
                        62%                62%                   64%                                                                     64%
 59%             59%            60%               60%                          57%

  1Q02           2Q02   3Q02     4Q02      1Q03   2Q03   3Q03    4Q03   1Q04   2Q04   3Q04   4Q04   1Q05   2Q05   3Q05    4Q05    1Q06    2Q06    3Q06
(*) Pro forma figures, excludes concession fees


                                                                               6
Revenues
                                        Toll Payment Method



                                                57%             52%
                                 64%

                                                                                    Cash
                                                                                    Eletronic
                                                43%             48%
                                 36%


                                 3Q04           3Q05            3Q06


  Concession Breakdown                                        Revenue Breakdown
                   Other                                        STP 1.5%     Other 2.1%
      ViaOeste
                     2%
 Via Lagos   16%
                                   AutoBAn
           2%              38%
   Ponte 4%

 Rodonorte 11%
                    27%                                                    96.4%
                                                         Toll

                 NovaDutra



                                                   7
Traffic




    Quarterly Historical Evolution                      3Q06 x 3Q05 – Concession Breakdown
         (Equivalent Vehicles – million)                             (Equivalent Vehicles )

                                                                                                          4.4%


                            78             80          3.2%
    59           65
                                           +2.4%
                                                              1.8%
                                                                        1.5%


                                                                                  Ponte       Via Lagos

    3Q03        3Q04        3Q05           3Q06    AutoBAn NovaDutra Rodonorte                            ViaOeste
                                                                                  -0.5%

                                                                                                -1.4%




                                                   8
Net Revenue & Total Cost

 Operating costs are coming back to long term trend...

                                 Cost as a Percentage of Net Revenue

                                                                                          550

                                                                       519

                                                   393
                                                                                  315                    Net Revenue

                               303                            290                 15%                    Other
                                           235                 16%                13%                    Payroll
                       194                 12%                 12%
                                            9%                                    21%                    Concession Fee
                       12%
                                                               23%
                               64 %




                                                                                          57 %
      R$ (million)




                       10%
                                                   60 %




                                                                       56 %
                                           22%
                       22%                                                        24%                    Third-Party
                                                               22%
                        1T03
                       30%                 33%
                                            1T04                1T05               1T06                  D&A
                                                               27%                27%
                       26%                 24%
                          3Q03                3Q04                3Q05               3Q06

                Other: insurance, rent, routine maintenance, marketing, travel and electronic payment.
                Third-Party Services: auditing, consulting and shared services.


                                                                         ...according to CCR’s expectation.
                                                                 9
Indebtedness

               Current portfolio’s operating cash generation ensures...

                              Gross Debt                                                       Net Debt




                                                  1,774
                                                                            1,126                               1,276
                                          1,467                                                      1,214
               1,269                              100%
R$ (million)




                                                             R$ (million)
                            1,184                                           1.6

                                           80%                                            679
                            69%
                56%                                                                                       1.2
                                                                                          1.1                   1.1

                3Q03        3Q04           3Q05   3Q06                      3Q03          3Q04        3Q05      3Q06

               Short Term           Long Term       In R$                           Net Debt
                 11.8%                88.2%                                         Net Debt / EBITDA LTM




                             ...strong net income distribution and unlevaraged Balance Sheet
                                                            10
Indebtedness

   Sources of funding are neither a growth boundary...


             Source of Funding                                     Long Term Debt Amortization
       Other
 104.5% - 106.4% CDI            BNDES
                              TJLP + 5.0%
                23%     22%                                                615




                                             R$ (million)
                                                                                   276
                28%     27%                                         214                   214
                                                                                                   143
   Debentures                                                70
                             Debentures
103.3% - 105% CDI
                          IGP-M + 9.5%-11%
                                                            2007    2008   2009   2010   2011    After 2011




                ...to the Company’s growth nor to refinancing its current portfolio.
                                                            11
Capital Expenditures

 Concessionaires capital expenditures are according...



               CAPEX (R$ MM)            3Q06           9M06       2006 (E)   2007(E)
               AutoBAn                   39.1          125.6       225.3       68.1
               NovaDutra                16.2            47.4        90.6       96.1
               Rodonorte                11.1            25.6        29.9       36.4
               Ponte                     1.0            8.0         14.1       14.8
               Via Lagos                 0.3            3.9         3.4        4.5
               ViaOeste                 49.5           118.3       187.0       43.4
                    1
               Other                     1.5            1.4         11.9       8.8
                 Consolidated           118.6          330.2       562.2      272.1
              (1) Includes CCR, Actua, Engelog, STP and Parques




                                               ...to their concession contract schedule.
                                                  12
New Businesses


     New Federal Concessions

     State of São Paulo New Concessions

     Secondary Market

     Mexico, Chile, United States and Canada




                                Brazil is still the main growth driver,
                            However, CCR will look for other markets.
                               13
14
Investor Relations


  Ricardo Froes - CFO
  ricardo.froes@ccrnet.com.br
  Tel: 55 (11) 3048-5921

  Arthur Piotto Filho - IR
  arthur.piotto@ccrnet.com.br
  Tel: 55 (11) 3048-5932

       BOVESPA: CCRO3
   Bloomberg: CCRO3 BZ
      Reuters: CCRO3.SA


  www.ccrnet.com.br         invest@ccrnet.com.br

                                15
3Q06 Results

Weitere ähnliche Inhalte

Was ist angesagt?

conoco phillips 2008Third Quarter
conoco phillips 2008Third Quarterconoco phillips 2008Third Quarter
conoco phillips 2008Third Quarterfinance1
 
conoco phillips 2008 First Quarter
conoco phillips 2008 First Quarterconoco phillips 2008 First Quarter
conoco phillips 2008 First Quarterfinance1
 
conoco phillips 2008Second Quarter
conoco phillips 2008Second Quarterconoco phillips 2008Second Quarter
conoco phillips 2008Second Quarterfinance1
 
tjx Annual Reports1999
tjx Annual Reports1999tjx Annual Reports1999
tjx Annual Reports1999finance14
 
Teleconferência de resultados 1 t03 (versão inglês)
Teleconferência de resultados 1 t03 (versão inglês)Teleconferência de resultados 1 t03 (versão inglês)
Teleconferência de resultados 1 t03 (versão inglês)Braskem_RI
 
coventry health care annual reports 2007
coventry health care annual reports 2007coventry health care annual reports 2007
coventry health care annual reports 2007finance27
 
Apresentação call 3 t12_eng
Apresentação call 3 t12_engApresentação call 3 t12_eng
Apresentação call 3 t12_engArteris S.A.
 
CLOrox 1%20Consolidated%20Earnings,%20Segment%20Information%20and%20Consoli...
CLOrox   1%20Consolidated%20Earnings,%20Segment%20Information%20and%20Consoli...CLOrox   1%20Consolidated%20Earnings,%20Segment%20Information%20and%20Consoli...
CLOrox 1%20Consolidated%20Earnings,%20Segment%20Information%20and%20Consoli...finance48
 
Venture Capital Exits Q3 06
  	Venture Capital Exits Q3 06    	Venture Capital Exits Q3 06
Venture Capital Exits Q3 06 mensa25
 
Anthem Southeast Historical Data
Anthem Southeast Historical DataAnthem Southeast Historical Data
Anthem Southeast Historical Datafinance4
 
Exxon Mobil Corporation 1Q'06 IR Supplement and Charts
Exxon Mobil Corporation 1Q'06 IR Supplement and ChartsExxon Mobil Corporation 1Q'06 IR Supplement and Charts
Exxon Mobil Corporation 1Q'06 IR Supplement and Chartsfinance1
 
coventry health care annual reports 2006
coventry health care annual reports 2006coventry health care annual reports 2006
coventry health care annual reports 2006finance27
 
Venture Backed Exits Q2 '07
 	Venture Backed Exits Q2 '07   	Venture Backed Exits Q2 '07
Venture Backed Exits Q2 '07 mensa25
 

Was ist angesagt? (20)

Investors meeting 1 q08 results
Investors meeting   1 q08 resultsInvestors meeting   1 q08 results
Investors meeting 1 q08 results
 
conoco phillips 2008Third Quarter
conoco phillips 2008Third Quarterconoco phillips 2008Third Quarter
conoco phillips 2008Third Quarter
 
2007 Results
2007 Results2007 Results
2007 Results
 
conoco phillips 2008 First Quarter
conoco phillips 2008 First Quarterconoco phillips 2008 First Quarter
conoco phillips 2008 First Quarter
 
2Q06 Results
2Q06 Results2Q06 Results
2Q06 Results
 
conoco phillips 2008Second Quarter
conoco phillips 2008Second Quarterconoco phillips 2008Second Quarter
conoco phillips 2008Second Quarter
 
tjx Annual Reports1999
tjx Annual Reports1999tjx Annual Reports1999
tjx Annual Reports1999
 
FY 2011 IFRS Results
FY 2011 IFRS ResultsFY 2011 IFRS Results
FY 2011 IFRS Results
 
Teleconferência de resultados 1 t03 (versão inglês)
Teleconferência de resultados 1 t03 (versão inglês)Teleconferência de resultados 1 t03 (versão inglês)
Teleconferência de resultados 1 t03 (versão inglês)
 
coventry health care annual reports 2007
coventry health care annual reports 2007coventry health care annual reports 2007
coventry health care annual reports 2007
 
Apresentação call 3 t12_eng
Apresentação call 3 t12_engApresentação call 3 t12_eng
Apresentação call 3 t12_eng
 
Genmab q3 2011
Genmab q3 2011Genmab q3 2011
Genmab q3 2011
 
CLOrox 1%20Consolidated%20Earnings,%20Segment%20Information%20and%20Consoli...
CLOrox   1%20Consolidated%20Earnings,%20Segment%20Information%20and%20Consoli...CLOrox   1%20Consolidated%20Earnings,%20Segment%20Information%20and%20Consoli...
CLOrox 1%20Consolidated%20Earnings,%20Segment%20Information%20and%20Consoli...
 
4 q11
4 q114 q11
4 q11
 
Venture Capital Exits Q3 06
  	Venture Capital Exits Q3 06    	Venture Capital Exits Q3 06
Venture Capital Exits Q3 06
 
Anthem Southeast Historical Data
Anthem Southeast Historical DataAnthem Southeast Historical Data
Anthem Southeast Historical Data
 
Exxon Mobil Corporation 1Q'06 IR Supplement and Charts
Exxon Mobil Corporation 1Q'06 IR Supplement and ChartsExxon Mobil Corporation 1Q'06 IR Supplement and Charts
Exxon Mobil Corporation 1Q'06 IR Supplement and Charts
 
coventry health care annual reports 2006
coventry health care annual reports 2006coventry health care annual reports 2006
coventry health care annual reports 2006
 
Q2 2011 financial_highlights
Q2 2011 financial_highlightsQ2 2011 financial_highlights
Q2 2011 financial_highlights
 
Venture Backed Exits Q2 '07
 	Venture Backed Exits Q2 '07   	Venture Backed Exits Q2 '07
Venture Backed Exits Q2 '07
 

Andere mochten auch (19)

Ring Road Concession Conference Call
Ring Road Concession Conference CallRing Road Concession Conference Call
Ring Road Concession Conference Call
 
Ccro3 apresentacao ccr_day10_en
Ccro3 apresentacao ccr_day10_enCcro3 apresentacao ccr_day10_en
Ccro3 apresentacao ccr_day10_en
 
Dee u slideshow
Dee u slideshowDee u slideshow
Dee u slideshow
 
Presentation 3Q14
Presentation 3Q14Presentation 3Q14
Presentation 3Q14
 
CCR Day 5 Presentation
CCR Day 5 PresentationCCR Day 5 Presentation
CCR Day 5 Presentation
 
1 q02 earnings results
1 q02 earnings results1 q02 earnings results
1 q02 earnings results
 
Presentation 3Q13
Presentation 3Q13Presentation 3Q13
Presentation 3Q13
 
Apimec 4 q06 results
Apimec   4 q06 resultsApimec   4 q06 results
Apimec 4 q06 results
 
Medical mneumonic
Medical mneumonicMedical mneumonic
Medical mneumonic
 
Presentation 1Q14
Presentation 1Q14Presentation 1Q14
Presentation 1Q14
 
Presentation 2Q12
Presentation 2Q12Presentation 2Q12
Presentation 2Q12
 
The story of my summer.
The story of my summer.The story of my summer.
The story of my summer.
 
Adverbios
AdverbiosAdverbios
Adverbios
 
Disclaimer 1
Disclaimer 1Disclaimer 1
Disclaimer 1
 
Virtual Reality meets Ausbildungsmarketing
Virtual Reality meets AusbildungsmarketingVirtual Reality meets Ausbildungsmarketing
Virtual Reality meets Ausbildungsmarketing
 
The story of the hammer.
The story of the hammer.The story of the hammer.
The story of the hammer.
 
Investors' Meeting - 1Q09 Results
Investors' Meeting - 1Q09 ResultsInvestors' Meeting - 1Q09 Results
Investors' Meeting - 1Q09 Results
 
Amistad
AmistadAmistad
Amistad
 
The story of the bird's nest.
The story of the bird's nest. The story of the bird's nest.
The story of the bird's nest.
 

Ähnlich wie Investors' meeting 3 q06 results

ApresentaçãO 1 Q07
ApresentaçãO 1 Q07ApresentaçãO 1 Q07
ApresentaçãO 1 Q07Localiza
 
Operating_Results_Q106_to_Q208
Operating_Results_Q106_to_Q208Operating_Results_Q106_to_Q208
Operating_Results_Q106_to_Q208finance38
 
bed bath&beyond AnnualReport2006
bed bath&beyond AnnualReport2006bed bath&beyond AnnualReport2006
bed bath&beyond AnnualReport2006finance44
 
2005 - 5th Us Analyst And Investor Meeting Financials
2005 - 5th Us Analyst And Investor Meeting   Financials2005 - 5th Us Analyst And Investor Meeting   Financials
2005 - 5th Us Analyst And Investor Meeting FinancialsEmbraer RI
 
thermo fisher 02CD4A18-7BC2-44BB-869A-463BE382B07C_ReconciliationofFinancialI...
thermo fisher 02CD4A18-7BC2-44BB-869A-463BE382B07C_ReconciliationofFinancialI...thermo fisher 02CD4A18-7BC2-44BB-869A-463BE382B07C_ReconciliationofFinancialI...
thermo fisher 02CD4A18-7BC2-44BB-869A-463BE382B07C_ReconciliationofFinancialI...finance40
 
thermo fisher 02CD4A18-7BC2-44BB-869A-463BE382B07C_ReconciliationofFinancial...
thermo fisher  02CD4A18-7BC2-44BB-869A-463BE382B07C_ReconciliationofFinancial...thermo fisher  02CD4A18-7BC2-44BB-869A-463BE382B07C_ReconciliationofFinancial...
thermo fisher 02CD4A18-7BC2-44BB-869A-463BE382B07C_ReconciliationofFinancial...finance40
 
thermo fisher 02CD4A18-7BC2-44BB-869A-463BE382B07C_ReconciliationofFinancialI...
thermo fisher 02CD4A18-7BC2-44BB-869A-463BE382B07C_ReconciliationofFinancialI...thermo fisher 02CD4A18-7BC2-44BB-869A-463BE382B07C_ReconciliationofFinancialI...
thermo fisher 02CD4A18-7BC2-44BB-869A-463BE382B07C_ReconciliationofFinancialI...finance40
 
thermo fisher 02CD4A18-7BC2-44BB-869A-463BE382B07C_ReconciliationofFinancialI...
thermo fisher 02CD4A18-7BC2-44BB-869A-463BE382B07C_ReconciliationofFinancialI...thermo fisher 02CD4A18-7BC2-44BB-869A-463BE382B07C_ReconciliationofFinancialI...
thermo fisher 02CD4A18-7BC2-44BB-869A-463BE382B07C_ReconciliationofFinancialI...finance40
 
thermo fisher 02CD4A18-7BC2-44BB-869A-463BE382B07C_ReconciliationofFinancialI...
thermo fisher 02CD4A18-7BC2-44BB-869A-463BE382B07C_ReconciliationofFinancialI...thermo fisher 02CD4A18-7BC2-44BB-869A-463BE382B07C_ReconciliationofFinancialI...
thermo fisher 02CD4A18-7BC2-44BB-869A-463BE382B07C_ReconciliationofFinancialI...finance40
 
agilent Operating_Results_Q106_to_Q108
agilent Operating_Results_Q106_to_Q108agilent Operating_Results_Q106_to_Q108
agilent Operating_Results_Q106_to_Q108finance38
 
thermo fisher ReconciliationFinancialInfoQ32008
thermo fisher ReconciliationFinancialInfoQ32008thermo fisher ReconciliationFinancialInfoQ32008
thermo fisher ReconciliationFinancialInfoQ32008finance40
 
thermo fisher ReconciliationFinancialInfoQ32008
thermo fisher ReconciliationFinancialInfoQ32008thermo fisher ReconciliationFinancialInfoQ32008
thermo fisher ReconciliationFinancialInfoQ32008finance40
 

Ähnlich wie Investors' meeting 3 q06 results (20)

Apimec – 2 q07 results
Apimec – 2 q07 resultsApimec – 2 q07 results
Apimec – 2 q07 results
 
Apimec 2 q06 results
Apimec   2 q06 resultsApimec   2 q06 results
Apimec 2 q06 results
 
Apimec – 3 q07 results
Apimec – 3 q07 resultsApimec – 3 q07 results
Apimec – 3 q07 results
 
Apimec – 4 q07 results
Apimec – 4 q07 resultsApimec – 4 q07 results
Apimec – 4 q07 results
 
ApresentaçãO 1 Q07
ApresentaçãO 1 Q07ApresentaçãO 1 Q07
ApresentaçãO 1 Q07
 
Apimec 2 q05 results
Apimec   2 q05 resultsApimec   2 q05 results
Apimec 2 q05 results
 
Presentation CCR - 3Q09
Presentation CCR - 3Q09Presentation CCR - 3Q09
Presentation CCR - 3Q09
 
Operating_Results_Q106_to_Q208
Operating_Results_Q106_to_Q208Operating_Results_Q106_to_Q208
Operating_Results_Q106_to_Q208
 
bed bath&beyond AnnualReport2006
bed bath&beyond AnnualReport2006bed bath&beyond AnnualReport2006
bed bath&beyond AnnualReport2006
 
2005 - 5th Us Analyst And Investor Meeting Financials
2005 - 5th Us Analyst And Investor Meeting   Financials2005 - 5th Us Analyst And Investor Meeting   Financials
2005 - 5th Us Analyst And Investor Meeting Financials
 
Apimec – 1 q07 results
Apimec – 1 q07 resultsApimec – 1 q07 results
Apimec – 1 q07 results
 
thermo fisher 02CD4A18-7BC2-44BB-869A-463BE382B07C_ReconciliationofFinancialI...
thermo fisher 02CD4A18-7BC2-44BB-869A-463BE382B07C_ReconciliationofFinancialI...thermo fisher 02CD4A18-7BC2-44BB-869A-463BE382B07C_ReconciliationofFinancialI...
thermo fisher 02CD4A18-7BC2-44BB-869A-463BE382B07C_ReconciliationofFinancialI...
 
thermo fisher 02CD4A18-7BC2-44BB-869A-463BE382B07C_ReconciliationofFinancial...
thermo fisher  02CD4A18-7BC2-44BB-869A-463BE382B07C_ReconciliationofFinancial...thermo fisher  02CD4A18-7BC2-44BB-869A-463BE382B07C_ReconciliationofFinancial...
thermo fisher 02CD4A18-7BC2-44BB-869A-463BE382B07C_ReconciliationofFinancial...
 
thermo fisher 02CD4A18-7BC2-44BB-869A-463BE382B07C_ReconciliationofFinancialI...
thermo fisher 02CD4A18-7BC2-44BB-869A-463BE382B07C_ReconciliationofFinancialI...thermo fisher 02CD4A18-7BC2-44BB-869A-463BE382B07C_ReconciliationofFinancialI...
thermo fisher 02CD4A18-7BC2-44BB-869A-463BE382B07C_ReconciliationofFinancialI...
 
thermo fisher 02CD4A18-7BC2-44BB-869A-463BE382B07C_ReconciliationofFinancialI...
thermo fisher 02CD4A18-7BC2-44BB-869A-463BE382B07C_ReconciliationofFinancialI...thermo fisher 02CD4A18-7BC2-44BB-869A-463BE382B07C_ReconciliationofFinancialI...
thermo fisher 02CD4A18-7BC2-44BB-869A-463BE382B07C_ReconciliationofFinancialI...
 
thermo fisher 02CD4A18-7BC2-44BB-869A-463BE382B07C_ReconciliationofFinancialI...
thermo fisher 02CD4A18-7BC2-44BB-869A-463BE382B07C_ReconciliationofFinancialI...thermo fisher 02CD4A18-7BC2-44BB-869A-463BE382B07C_ReconciliationofFinancialI...
thermo fisher 02CD4A18-7BC2-44BB-869A-463BE382B07C_ReconciliationofFinancialI...
 
Investors' Meeting Presentation - 4Q09 Results
Investors' Meeting Presentation - 4Q09 ResultsInvestors' Meeting Presentation - 4Q09 Results
Investors' Meeting Presentation - 4Q09 Results
 
agilent Operating_Results_Q106_to_Q108
agilent Operating_Results_Q106_to_Q108agilent Operating_Results_Q106_to_Q108
agilent Operating_Results_Q106_to_Q108
 
thermo fisher ReconciliationFinancialInfoQ32008
thermo fisher ReconciliationFinancialInfoQ32008thermo fisher ReconciliationFinancialInfoQ32008
thermo fisher ReconciliationFinancialInfoQ32008
 
thermo fisher ReconciliationFinancialInfoQ32008
thermo fisher ReconciliationFinancialInfoQ32008thermo fisher ReconciliationFinancialInfoQ32008
thermo fisher ReconciliationFinancialInfoQ32008
 

Mehr von CCR Relações com Investidores (20)

CCR PRESENTATION 4Q18
CCR PRESENTATION 4Q18CCR PRESENTATION 4Q18
CCR PRESENTATION 4Q18
 
Apresentação de Resultado- CCR 4T18
Apresentação de Resultado- CCR 4T18Apresentação de Resultado- CCR 4T18
Apresentação de Resultado- CCR 4T18
 
Apresentação 2T18
Apresentação 2T18Apresentação 2T18
Apresentação 2T18
 
2Q18 Presentation
2Q18 Presentation2Q18 Presentation
2Q18 Presentation
 
1Q18 Presentation
1Q18 Presentation1Q18 Presentation
1Q18 Presentation
 
Apresentação 1T18
Apresentação 1T18Apresentação 1T18
Apresentação 1T18
 
4Q17 Earnings Presentation
4Q17 Earnings Presentation4Q17 Earnings Presentation
4Q17 Earnings Presentation
 
Apresentação 4T17
Apresentação 4T17Apresentação 4T17
Apresentação 4T17
 
CCR Day 13 Presentation
CCR Day 13 Presentation CCR Day 13 Presentation
CCR Day 13 Presentation
 
CCR Day 13
CCR Day 13 CCR Day 13
CCR Day 13
 
Presentation 3Q17
Presentation 3Q17  Presentation 3Q17
Presentation 3Q17
 
Apresentação 3T17
Apresentação 3T17Apresentação 3T17
Apresentação 3T17
 
Presentations 2Q17
Presentations 2Q17Presentations 2Q17
Presentations 2Q17
 
Apresentação 2T17
Apresentação 2T17Apresentação 2T17
Apresentação 2T17
 
Presentation 2Q17
Presentation 2Q17Presentation 2Q17
Presentation 2Q17
 
Apresentação 2 t17
Apresentação 2 t17Apresentação 2 t17
Apresentação 2 t17
 
Presentation 1Q17
Presentation 1Q17 Presentation 1Q17
Presentation 1Q17
 
Apresentação 1T17
Apresentação 1T17Apresentação 1T17
Apresentação 1T17
 
Presentation 4Q16
Presentation 4Q16   Presentation 4Q16
Presentation 4Q16
 
Apresentação 4 t16
Apresentação 4 t16  Apresentação 4 t16
Apresentação 4 t16
 

Investors' meeting 3 q06 results

  • 1. 3Q06 Earnings Results November 14, 2006
  • 2. Forward Looking Statement This presentation contains certain statements that are neither reported financial results or other historical information. They are forward-looking statements. Because these forward-looking statements are subject to risks and uncertainties, actual future results may differ materially from those expressed in or implied by the statements. Many of these risks and uncertainties relate to factors that are beyond CCR’s ability to control or estimate precisely, such as future market conditions, currency fluctuations, the behavior of other market participants, the actions of governmental regulators, the Company's ability to continue to obtain sufficient financing to meet its liquidity needs; and changes in the political, social and regulatory framework in which the Company operates or in economic or technological trends or conditions, inflation and consumer confidence, on a global, regional or national basis. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this document. CCR does not undertake any obligation to publicly release any revisions to these forward looking statements to reflect events or circumstances after the date of this presentation. 2
  • 3. Agenda Highlights Results Outlook 3
  • 4. Highlights Operating Consolidated traffic recovery, when compared to recent quarters, up by 2.4% over the third quarter, 2005. 25.4% Increase in AVI users, totaling 632th. Corporate On August 31, 2006, the Company initiated a dividend payment, which was recorded as anticipated dividends regarding FY 2006 results, amounting to R$ 254.0 million, representing a dividend payout ratio of 131% over 1H06’s Net Income. 4
  • 5. Results 3Q06’s results reflect a combination of factors... R$ Million 3Q05 3Q06 chg % 9M05 9M06 chg % Net Revenues 519.3 550.0 5.9% 1,402.4 1,577.4 12.5% Total Cost (1) 290.5 315.5 8.6% 830.3 954.9 15.0% EBIT 228.9 234.6 2.5% 572.1 622.5 8.8% EBIT Margin 44.1% 42.7% -1.4 p.p 40.8% 39.5% -1.3 p.p Depreciation & Amortization (2) 81.3 87.9 8.1% 221.1 261.0 18.1% EBITDA 310.2 322.4 3.9% 793.2 883.6 11.4% EBITDA margin 59.7% 58.6% -1.1 p.p 56.6% 56.0% -0.6 p.p Net Financial Result 47.9 (48.7) -201.7% (25.0) (143.0) 472.8% Net Income 182.3 121.1 -33.6% 347.9 314.5 -9.6% Net Financial Result (3) (47.1) (48.7) 3.7% (120.0) (143.0) 19.3% Net Income (3) 120.2 121.1 0.9% 285.8 314.5 10.1% (1) Total Cost + Administrative Expenses (2) Includes Prepaid Expenses (3) Pro forma amounts, excluding fiscal contingencies reversin in 3Q05 – net amount of R$ 62.1 million …operating costs and financial result. 5
  • 6. Operating Margin Evolution EBITDA x EBITDA Margin R$ (million) 310 309 322 299 259 263 216 218 224 161 170 174 151 130 128 122 119 108 107 60% 58% 59% 53% 55% 55% 54% 55% 56% 49% 51% 52% 51% 46% 46% 47% 48% 47% 44% 1Q02 2Q02 3Q02 4Q02 1Q03 2Q03 3Q03 4Q03 1Q04 2Q04 3Q04 4Q04 1Q05 2Q05 3Q05 4Q05 1Q06 2Q06 3Q06 Adjusted EBITDA x Adjusted EBITDA margin R$ (million) 375 374 386 362 319 326 266 269 276 211 218 203 196 163 162 155 152 138 137 72% 70% 70% 67% 66% 68% 68% 67% 68% 68% 62% 62% 64% 64% 59% 59% 60% 60% 57% 1Q02 2Q02 3Q02 4Q02 1Q03 2Q03 3Q03 4Q03 1Q04 2Q04 3Q04 4Q04 1Q05 2Q05 3Q05 4Q05 1Q06 2Q06 3Q06 (*) Pro forma figures, excludes concession fees 6
  • 7. Revenues Toll Payment Method 57% 52% 64% Cash Eletronic 43% 48% 36% 3Q04 3Q05 3Q06 Concession Breakdown Revenue Breakdown Other STP 1.5% Other 2.1% ViaOeste 2% Via Lagos 16% AutoBAn 2% 38% Ponte 4% Rodonorte 11% 27% 96.4% Toll NovaDutra 7
  • 8. Traffic Quarterly Historical Evolution 3Q06 x 3Q05 – Concession Breakdown (Equivalent Vehicles – million) (Equivalent Vehicles ) 4.4% 78 80 3.2% 59 65 +2.4% 1.8% 1.5% Ponte Via Lagos 3Q03 3Q04 3Q05 3Q06 AutoBAn NovaDutra Rodonorte ViaOeste -0.5% -1.4% 8
  • 9. Net Revenue & Total Cost Operating costs are coming back to long term trend... Cost as a Percentage of Net Revenue 550 519 393 315 Net Revenue 303 290 15% Other 235 16% 13% Payroll 194 12% 12% 9% 21% Concession Fee 12% 23% 64 % 57 % R$ (million) 10% 60 % 56 % 22% 22% 24% Third-Party 22% 1T03 30% 33% 1T04 1T05 1T06 D&A 27% 27% 26% 24% 3Q03 3Q04 3Q05 3Q06 Other: insurance, rent, routine maintenance, marketing, travel and electronic payment. Third-Party Services: auditing, consulting and shared services. ...according to CCR’s expectation. 9
  • 10. Indebtedness Current portfolio’s operating cash generation ensures... Gross Debt Net Debt 1,774 1,126 1,276 1,467 1,214 1,269 100% R$ (million) R$ (million) 1,184 1.6 80% 679 69% 56% 1.2 1.1 1.1 3Q03 3Q04 3Q05 3Q06 3Q03 3Q04 3Q05 3Q06 Short Term Long Term In R$ Net Debt 11.8% 88.2% Net Debt / EBITDA LTM ...strong net income distribution and unlevaraged Balance Sheet 10
  • 11. Indebtedness Sources of funding are neither a growth boundary... Source of Funding Long Term Debt Amortization Other 104.5% - 106.4% CDI BNDES TJLP + 5.0% 23% 22% 615 R$ (million) 276 28% 27% 214 214 143 Debentures 70 Debentures 103.3% - 105% CDI IGP-M + 9.5%-11% 2007 2008 2009 2010 2011 After 2011 ...to the Company’s growth nor to refinancing its current portfolio. 11
  • 12. Capital Expenditures Concessionaires capital expenditures are according... CAPEX (R$ MM) 3Q06 9M06 2006 (E) 2007(E) AutoBAn 39.1 125.6 225.3 68.1 NovaDutra 16.2 47.4 90.6 96.1 Rodonorte 11.1 25.6 29.9 36.4 Ponte 1.0 8.0 14.1 14.8 Via Lagos 0.3 3.9 3.4 4.5 ViaOeste 49.5 118.3 187.0 43.4 1 Other 1.5 1.4 11.9 8.8 Consolidated 118.6 330.2 562.2 272.1 (1) Includes CCR, Actua, Engelog, STP and Parques ...to their concession contract schedule. 12
  • 13. New Businesses New Federal Concessions State of São Paulo New Concessions Secondary Market Mexico, Chile, United States and Canada Brazil is still the main growth driver, However, CCR will look for other markets. 13
  • 14. 14
  • 15. Investor Relations Ricardo Froes - CFO ricardo.froes@ccrnet.com.br Tel: 55 (11) 3048-5921 Arthur Piotto Filho - IR arthur.piotto@ccrnet.com.br Tel: 55 (11) 3048-5932 BOVESPA: CCRO3 Bloomberg: CCRO3 BZ Reuters: CCRO3.SA www.ccrnet.com.br invest@ccrnet.com.br 15